Eight workers in a nursing home in Stralsund, Vorpommern-Rogen, Germany received large doses of the vaccine BioNTech-Pfizer What caused influenza-like symptoms to appear on 4 of the workers.
According to a newspaper report Mirror The caregivers ended up in the hospital after they were given 5 times the recommended dose of the Corona vaccine.
Corona overdose–
Officials from Vorpommern-Rogen said the doses were given to eight employees, aged between 66 and 82, at a nursing home in the Hanseatic city of Stralsund on December 27.
When the error was discovered, officials sent half of the staff home, however the other half were sent to hospital for observation after showing flu-like symptoms.
“I am deeply sorry for the accident. The doses were given in error, and this individual case is due to individual errors, and I hope that all those affected will not suffer from any serious side effects,” said Stephan Kirth, director of the Forbomeren-Rogaine region.
District officials cited an earlier statement from BioNTech He indicated that large doses were used in the first phase of clinical trials of the vaccine without any serious consequences BioNtech Previously, larger doses were tested in a Phase 1 study without serious consequences.
In the days leading up to Christmas, the European Medicines Agency approved its use BioNTech-Pfizer jab Across the European Union, startups in Germany have faced another problem in the week since then.
However, some German regions refused to use the vaccine doses they received over the weekend due to concerns that the cold conditions needed to ship the vaccine had stopped during delivery.
The vaccine must be stored at very low temperatures, reaching about 70 ° C, before transporting it to distribution centers in cold boxes filled with dry ice.
Once out of the extremely low temperature storage, the vaccine must be kept at 2 ° C to 8 ° C to remain effective for up to 5 days, and temperature tracking devices have shown that thousands of vaccines may not have been kept cold enough during transit.
– .
